% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • larrystone13 larrystone13 Nov 21, 2012 12:37 PM Flag

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160 " link

    Street Insider
    Sarepta Therapeutics (SRPT) Jumps on Bullish Comments
    November 21, 2012 9:18 AM EST
    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.

1.12-0.04(-3.45%)Oct 26 4:00 PMEDT